PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24225N0443URINE and ORAL DRUG testing — Central Tox LLC

Central Tox LLC holds $2.0M across 31 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 2 related awards under parent 36C24222D0030. PoP ended Mar 31, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

242-Network Contract Office 02 (36C242)

Awarding office

Central Tox LLC

Recipient

Mar 31, 2026

PoP end

$524K

Obligated

$524K

Potential

621511

NAICS

Q301

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Central Tox LLC — $90

Contract facts

Federal

Contract number36C24225N0443

Also listed as36C242-25-N-0443

Also listed as36C24222D0030-36C24225N0443

Agency242-Network Contract Office 02 (36C242)

Awarding office242-Network Contract Office 02 (36C242)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentCentral Tox LLC

CAGE8SRD9

UEIPNKHDVRXZC29

NAICS621511

No full NAICS 621511 intel page yet. Browse NAICS intelligence

PSCQ301

Parent IDIQ / IDV36C24222D0030

Place of performanceNORTHPORT NY

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

PoP startApr 1, 2025

PoP end (current)Mar 31, 2026

Obligated$524K

Current value$524K

Potential value$524K

URINE AND ORAL DRUG TESTING is a federal award for 242-Network Contract Office 02 (36C242) held by Central Tox LLC. Estimated value $524K ($524K obligated). Current period of performance ends Mar 31, 2026. Place of performance: NORTHPORT NY.

Recompete timing

Public

● Past PoP end (143 days ago)

Current PoP ended Mar 31, 2026 (143 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Central Tox LLC — $2.0M obligated across 31 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($2.0M) · all agencies

Department of Veterans Affairs (VA)$1.8M · 90%Department of Defense (DOD)$191K · 10%

Open full company profile →

Related awards

Same parent · incumbent

36C24226N0349

ORDER FOR URINE AND DRUG TESTING FOR NORTHPORT

$530K

Mar 31, 2027

36C24224N0332

URINALYSIS & ORAL DRUG TESTING

$120K

Mar 31, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24225N0443?

36C24225N0443 (URINE and ORAL DRUG testing) is a 242-Network Contract Office 02 (36C242) award with a potential value of $524K, currently held by Central Tox LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C242-25-N-0443?

36C242-25-N-0443 is the dashed form of PIID 36C24225N0443 (URINE and ORAL DRUG testing), held by Central Tox LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24225N0443?

242-Network Contract Office 02 (36C242) awarded 36C24225N0443 to Central Tox LLC (potential $524K).

Who is the incumbent on 36C24225N0443?

Central Tox LLC is the incumbent with $2.0M across 31 related awards in SCOUT’s public footprint. The current period of performance ends Mar 31, 2026.

When does Central Tox LLC’s 36C24225N0443 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Apr 14, 2026